Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

PROCEDURE(1)
1 unique interventions1 categories

Analytics

Trial Phases

No phase data

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT03416101Completed
Siewert Type II Esophageal Adenocarcinoma: Relationship Between Histology and Survival
Siewert Type II Adenocarcinoma of Esophagogastric Junction
PrincipalinvestigatorStart date: 2007-01-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Department of Medical and Surgical Sciences

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

peichun sun, MD,PH.D

Henan Provincial People's Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Siewert Type II Adenocarcinoma of Esophagogastric Junction
Similarity Score30%

lei wang, MD,PH.D

General Hospital of Ningxia Medical University

Moderately Similar
1 trials

Shared therapeutic areas:

Siewert Type II Adenocarcinoma of Esophagogastric Junction
Similarity Score30%

Andrey Ryabov, MD, PhD

P.Herzen Moscow Oncological Research Institute

Moderately Similar
5 trials

Shared therapeutic areas:

Siewert Type II Adenocarcinoma of Esophagogastric Junction
Similarity Score30%

xuejun sun, MD,PH.D

First Affiliated Hospital Xi'an Jiaotong University

Moderately Similar
1 trials

Shared therapeutic areas:

Siewert Type II Adenocarcinoma of Esophagogastric Junction
Similarity Score30%

Jian-Kun Hu, M.D. Ph.D.

West China Hospital

Moderately Similar
4 trials

Shared therapeutic areas:

Siewert Type II Adenocarcinoma of Esophagogastric Junction
Similarity Score30%

wei wang, M.D.,Ph.D

Guangdong PHTCM

Moderately Similar
1 trials

Shared therapeutic areas:

Siewert Type II Adenocarcinoma of Esophagogastric Junction
Similarity Score30%

Nuriddin Abdulkhakimov, PhD

P.Herzen Moscow Oncological Research Institute

Moderately Similar
1 trials

Shared therapeutic areas:

Siewert Type II Adenocarcinoma of Esophagogastric Junction
Similarity Score30%

xianli he, MD,PH.D

Tang-Du Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Siewert Type II Adenocarcinoma of Esophagogastric Junction
Similarity Score30%

Melissa Lumish, MD

University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center

Moderately Similar
1 trials

Shared therapeutic areas:

Siewert Type II Adenocarcinoma of Esophagogastric Junction
Similarity Score30%

xiaohua li, MD,PH.D

Xijing Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

Siewert Type II Adenocarcinoma of Esophagogastric Junction
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT03416101PrincipalInvestigator

Siewert Type II Esophageal Adenocarcinoma: Relationship Between Histology and Survival

Siewert Type II Adenocarcinoma of Esophagogastric Junction
Completed

All 1 trials loaded